Пенный гель La Roche Posay Effaclar

Acne affects 80% of teenagers and 40% of adults worldwide. 70% say their acne has lowered their self-confidence. 

But patients sometimes have to wait months before making an appointment with a dermatologist; others just don't have the resources.  

It is estimated that only 5% to 10% of people in the world have access to a dermatologist.

It is therefore La Roche-Posay's wish to make dermatological expertise accessible to everyone. 

Based on this wish, La Roche-Posay has developed the Effaclar Spotscan; a tool that can make an accurate diagnosis of acne based on advanced artificial intelligence. 

A tool accessible to everyone!